OBJECTIVE AND TIMING OF DRUG DISPOSITION STUDIES .4. PHENYLBUTAZONE FORMULATIONS - INVITRO DISSOLUTION AND INVIVO PERFORMANCE

被引：8

作者：

LEESON, LJ

SHINAL, EC

LUKAS, G

ZAK, SB

WEINER, M

机构：

[1] CIBA GEIGY CORP,PHARM DIV,RES DEPT,ARDSLEY,NY 10502

[2] CIBA GEIGY CORP,PHARM DIV,RES DEPT,SUMMIT,NJ 07901

来源：

关键词：

D O I：

10.3109/03602537508993761

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：277 / 284

页数：8

共 8 条

[1] [Anonymous], 1971, STAT PRINCIPLES EXPT
[2] BURNS JJ, 1953, J PHARMACOL EXP THER, V109, P346
[3] HOGDEN CAM, 1957, J PHARMACOL EXP THER, V120, P540
[4] LEESON LJ, 1972, PHARMACOLOGY, V8, P154
[5] INFLUENCE OF ROUTE OF ADMINISTRATION ON DRUG AVAILABILITY
ROWLAND, M
[J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1972, 61 (01) : 70 - &
[6] ABSORPTION RATE CONSTANTS CALCULATED ACCORDING TO ONE-COMPARTMENT OPEN MODEL WITH FIRST-ORDER ABSORPTION - IMPLICATIONS IN IN-VIVO-IN-VITRO CORRELATIONS
WAGNER, JG
[J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1970, 59 (07) : 1049 - &
[7] Wagner JG, 1971, BIOPHARMACEUTICS REL
[8] 1970, US PHARMACOPOEIA, P934